1 unknown. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
Follow Yongyong MA: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Daratumumab/Daratumumab and Hyaluronidase-fihj in Combination With Pomalidomide and Dexamethasone for the Treatment of Patients With Newly Diagnosed AL Amyloidosis: a Prospective, Multicenter, Single-arm Study Daratumumab/daratumumab and hyaluronidase-fihj, Pomalidomide, Dexamethasone - Amyloid Light-chain Amyloidosis | Not applicable | Unknown | Yongyong MA | 20 | 2024-03-01 | 2024-06-12 |
Immunoglobulin Light-chain Amyloidosis (1)
Dexamethasone (1) · daratumumab (1) · darlin protein, Dictyostelium (1) · pomalidomide (1)
China (1)